Cellular Avidity Platform for Next-Gen Immunotherapy Selection

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Creative Biolabs delivers specialized functional screening services centered on cellular avidity quantification to de-risk candidate pipelines in TCR-T, CAR-T, and antibody-based cell engager development. Conventional monovalent affinity metrics routinely fail to predict true clinical potency, cell-killing kinetics, or tumor eradication due to their omission of membrane dynamics, receptor clustering, and co-stimulatory coordination. Advanced microfluidic hydrodynamic retention arrays and precision shear-stress detachment systems resolve this barrier by measuring collective intercellular mechanical engagement under physiological flow.

Introduction

Cellular avidity quantifies the cumulative intercellular binding strength established between an effector immune cell and its cognate target cell across the assembled immunological synapse. Landmark studies demonstrate that conventional biophysical methods, including monovalent surface plasmon resonance and fluorescent multimers, often fail to predict anti-tumor cytotoxicity, cytokine secretion, and persistence. By integrating the concerted effects of receptor density, membrane compliance, co-receptor clustering, and cytoskeletal tension under controlled fluid shear stress, cellular avidity serves as an accurate functional biomarker of T-cell potency.

Fig.1 The principle behind the cell avidity analyzer. (OA Literature) Fig.1 The operational mechanism for cell avidity analysis.¹

Our Service

Creative Biolabs provides an integrated biophysical evaluation pipeline designed to rescue developmental programs from the pitfalls of single-molecule affinity assays. Traditional surface plasmon resonance and soluble multimer staining measure isolated molecular kinetics that neglect the complex geometry of the immunological synapse, the mechanical stabilization provided by co-receptors, and integrin-mediated adhesion cascades. By transitioning from molecular affinity to true cellular avidity, our service resolves critical developmental bottlenecks for research teams engineering modern cellular immunotherapies.

Identification of Functional Clones Lacking Supraphysiological Toxicity: Selecting candidate receptors based solely on ultra-high affinity frequently induces T-cell exhaustion, off-target recognition, and life-threatening cross-reactivity. Creative Biolabs quantifies the actual shear force required to break live immune-target cell conjugations, isolating clones that occupy the therapeutic window of high anti-tumor cytotoxicity coupled with optimal physiological dissociation.
Label-Free Live Cell Sorting and Viable Clone Recovery: Utilizing calibrated fluid shear stress channels, our platform can process heterogeneous repertoires to recover functional, viable T-cell clones with exceptional purity without relying on external fluorophores or perturbing antibody labels that interfere with native cell states.
Rapid High-Throughput De-risking: Thousands of distinct immune-to-target cellular interactions are characterized per run. This high-density assessment identifies non-functional or low-avidity candidates within days, conserving valuable primary patient material and non-renewable viral vector lots.

Discover How We Can Help - Request a Consultation.

What We Can Offer

Creative Biolabs provides a suite of advanced, non-infringing biophysical platforms engineered to profile cell-cell adhesion dynamics across diverse biological matrices and solid-tumor formats:

Analysis of Cellular Avidity Platform for Next-Gen Immunotherapy Selection. (Creative Biolabs Original)

Microfluidic Laminar Shear Stress Dissociation Systems: Precision microchannels enable controlled effector-target cell interactions and stepwise shear stress (0.1 to >15 Pa). Automated imaging quantifies detachment thresholds for label-free fractionation of high-avidity effectors.
Orthogonal Hydrodynamic and Dielectrophoretic (DEP) Micromanipulation: Hydrodynamic micro-cavity arrays and localized alternating electric fields enable precise cell pairing, contact timing, and tensile rupture force measurements.
Dynamic Biomembrane Force and Adhesion Kinetics Profiling: Mechanical assays probing discrete cellular units that resolve rupture force signatures and intercellular bond lifetimes across resting, activated, and exhausted states, yielding precise biophysical readouts of target antigen sensitivity.

Our Workflow

To initiate an avidity profiling campaign, clients provide characterized biological specimens aligned with project specifications:

Target Cell Systems: Cryopreserved or proliferating target cells accompanied by quantified surface antigen expression profiles.
Effector Cell Populations: Purified primary human peripheral blood mononuclear cells (PBMCs), engineered CAR T cells, transduced T-cell receptor (TCR) T cell libraries, or tumor-infiltrating lymphocyte (TIL) suspensions.
Targeting Reagents / Soluble Controls (Optional): Characterized recombinant bispecific antibodies, control peptide-MHC monomers, or validation reference antibodies for assay standardization.

Workflow of Cellular Avidity Platform for Next-Gen Immunotherapy Selection. (Creative Biolabs Original)

Final Deliverables:

Comprehensive quantitative interaction reports containing detachment curves, shear adhesion indices, and comparative population histograms.
Complete digital time-lapse microscopic data packages tracking interaction and detachment kinetics across all applied force regimes.
Viable, physically segregated high-avidity and low-avidity cellular fractions shipped under validated cold-chain conditions for immediate downstream expansion, RNA sequencing, or phenotypic testing.

Benefits

High-throughput cellular avidity characterization platforms capable of screening tens of thousands of individual cell-to-cell interaction events per run.
Label-free, physiological shear-stress separation systems that isolate highly reactive T cells while completely preserving native surface receptor phenotypes.
Advanced microfluidic channel configurations providing uniform laminar flow fields with cross-sectional variance below 1%.

FAQs

Q: How does cellular avidity measurement differ from surface plasmon resonance (SPR)?

A: Surface plasmon resonance assesses the 1:1 binding affinity between isolated, immobilized recombinant proteins and soluble ligands in an artificial environment. In contrast, our cellular avidity platform measures the cumulative physical binding force between intact, living immune cells and target cells. This captures crucial biological factors that SPR cannot measure, such as local receptor density, spatial reorganization within the immunological synapse, membrane fluidity, and co-receptor stabilization.

Q: Why is high cellular avidity a more reliable predictor of in vivo efficacy than multimer staining?

A: Soluble peptide-MHC multimers measure receptor dissociation rates against engineered peptide complexes, but they cannot assess whether an effector cell can form a stable, functional immunological synapse with a living tumor cell expressing endogenous, low-density antigens. Cells that stain strongly for multimer may still fail to kill tumor targets in vivo if co-stimulatory interactions are defective. By directly quantifying the mechanical force sustained by the complete, functional synapse, cellular avidity provides a clinically relevant metric that correlates strongly with tumor clearance and overall survival in preclinical animal models.

Partner with Us

Creative Biolabs operates as a specialized biophysical and immunology partner, providing end-to-end cellular avidity platforms, customized microfluidics solutions, and comprehensive functional screening workflows. Our scientific team supports your project from initial experimental architecture through to advanced downstream clonal recovery, delivering actionable data that accelerates lead discovery and mitigates translational risk. Connect directly with our immunology team to schedule a technical evaluation and discover how our cellular avidity platform can accelerate your therapy pipeline.

Reference

Wang, Yao et al. “Acoustic Force-Based Cell-Matrix Avidity Measurement in High Throughput.” Biosensors vol. 13,1 95. 6 Jan. 2023. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.3390/bios13010095.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.